UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2012

or

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission file number: 000-10030

APPLE INC.

(Exact name of Registrant as specified in its charter)

California

94-2404110

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer Identification No.)

1 Infinite Loop

Cupertino, California

95014

(Address of principal executive offices)

(Zip Code)

Registrant s telephone number, including area code: (408) 996-1010

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the

Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes No

Indicate by check mark whether the registrant has submitted electronically

and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the

registrant was required to submit and post such files).

Yes No

Indicate by check mark whether the registrant is a large accelerated filer,

an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

(Do not check if a smaller reporting company)

Smaller reporting company

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes No

935,062,000 shares of common stock issued and outstanding as of April 13,

2012

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)

(in millions, except number of shares which are reflected in thousands and per share amounts)

September 30,

September 30,

September 30,

September 30,

Three Months Ended

Six Months Ended

March 31,

2012

March 26,

2011

March 31,

2012

March 26,

2011

Net sales

39,186

24,667

85,519

51,408

Cost of sales

20,622

14,449

46,252

30,892

Gross margin

18,564

10,218

39,267

20,516

Operating expenses:

Research and development

841

581

1,599

1,156

Selling, general and administrative

2,339

1,763

4,944

3,659

Total operating expenses

3,180

2,344

6,543

4,815

Operating income

15,384

7,874

32,724

15,701

Other income and expense

148

26

285

162

Income before provision for income taxes

15,532

7,900

33,009

15,863

Provision for income taxes

3,910

1,913

8,323

3,872

Net income

11,622

5,987

24,686

11,991

Earnings per common share:

Basic

12.45

6.49

26.48

13.02

Diluted

12.30

6.40

26.17

12.83

Shares used in computing earnings per share:

Basic

933,582

923,196

932,265

921,245

Diluted

944,893

935,944

943,185

934,549

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)

(in millions, except number of shares which are reflected in thousands)

September 30,

September 30,

March 31,

2012

September 24,

2011

ASSETS:

Current assets:

Cash and cash equivalents

10,121

9,815

Short-term marketable securities

18,417

16,137

Accounts receivable, less allowances of $83 and $53, respectively

7,042

5,369

Inventories

1,102

776

Deferred tax assets

2,253

2,014

Vendor non-trade receivables

6,727

6,348

Other current assets

5,050

4,529

Total current assets

50,712

44,988

Long-term marketable securities

81,638

55,618

Property, plant and equipment, net

8,847

7,777

Goodwill

1,141

896

Acquired intangible assets, net

3,604

3,536

Other assets

4,992

3,556

Total assets

150,934

116,371

LIABILITIES AND SHAREHOLDERS EQUITY:

Current liabilities:

Accounts payable

17,011

14,632

Accrued expenses

9,778

9,247

Deferred revenue

5,247

4,091

Total current liabilities

32,036

27,970

Deferred revenue - non-current

2,446

1,686

Other non-current liabilities

13,954

10,100

Total liabilities

48,436

39,756

Commitments and contingencies

Shareholders equity:

Common stock, no par value; 1,800,000 shares authorized; 934,982 and 929,277 shares issued and outstanding,

respectively

14,850

13,331

Retained earnings

87,124

62,841

Accumulated other comprehensive income

524

443

Total shareholders equity

102,498

76,615

Total liabilities and shareholders equity

150,934

116,371

See accompanying Notes to Condensed Consolidated Financial Statements.

APPLE INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)

(in millions)

September 30,

September 30,

Six Months Ended

March 31,

2012

March 26,

2011

Cash and cash equivalents, beginning of the period

9,815

11,261

Operating activities:

Net income

24,686

11,991

Adjustments to reconcile net income to cash generated by operating activities:

Depreciation, amortization and accretion

1,461

790

Share-based compensation expense

844

586

Deferred income tax expense

2,915

1,563

Changes in operating assets and liabilities:

Accounts receivable, net

(1,663

(288

Inventories

(326

121

Vendor non-trade receivables

(379

(883

Other current and non-current assets

(1,510

(1,886

Accounts payable

2,809

1,626

Deferred revenue

1,916

698

Other current and non-current liabilities

778

1,674

Cash generated by operating activities

31,531

15,992

Investing activities:

Purchases of marketable securities

(85,022

(42,260

Proceeds from maturities of marketable securities

7,702

10,211

Proceeds from sales of marketable securities

49,052

21,705

Payments made in connection with business acquisitions, net of cash acquired

(350

Payments for acquisition of property, plant and equipment

(2,778

(1,838

Payments for acquisition of intangible assets

(160

(81

Other

(48

12

Cash used in investing activities

(31,604

(12,251

Financing activities:

Proceeds from issuance of common stock

377

494

Excess tax benefits from equity awards

636

740

Taxes paid related to net share settlement of equity awards

(634

(258

Cash generated by financing activities

379

976

Increase in cash and cash equivalents

306

4,717

Cash and cash equivalents, end of the period

10,121

15,978

Supplemental cash flow disclosure:

Cash paid for income taxes, net

4,835

1,913

See accompanying Notes to Condensed Consolidated Financial Statements.

Apple Inc.

Notes to Condensed Consolidated Financial Statements (Unaudited)

Note 1 Summary of Significant Accounting Policies

Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,

manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and

applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the

Company sells a variety of third-party iPhone, iPad, Macintosh ( Mac ), and iPod compatible products including application software and various accessories through its online and retail stores. The Company sells to consumers, small and

mid-sized businesses, and education, enterprise and government customers.

Basis of Presentation and Preparation

The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions

have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the

amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Prior period costs associated with the Company s high-profile retail stores have been

reclassified to conform to the current period s presentation. Refer to Note 7, Segment Information and Geographic Data, of this Form 10-Q.

These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal

year ended September 24, 2011, included in its Annual Report on Form 10-K (the 2011 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year

2012 will include 53-weeks and ends on September 29, 2012. An additional week has been included in the first quarter of 2012 to realign the Company s fiscal quarters more closely to calendar quarters. Unless otherwise stated, references to

particular years or quarters refer to the Company s fiscal years ended in September and the associated quarters of those fiscal years.

Earnings Per Common Share

Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares

of common stock outstanding during the period. Diluted earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to

include the number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the

Company s employee stock purchase plan and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per common share by application of the treasury stock method.

Under the treasury stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.

The following table sets forth the computation of basic and diluted earnings per common

share for the three- and six-month periods ended March 31, 2012 and March 26, 2011 (in thousands, except net income in millions and per share amounts):

September 30,

September 30,

September 30,

September 30,

Three Months Ended

Six Months Ended

March 31,

2012

March 26,

2011

March 31,

2012

March 26,

2011

Numerator:

Net income

11,622

5,987

24,686

11,991

Denominator:

Weighted-average shares outstanding

933,582

923,196

932,265

921,245

Effect of dilutive securities

11,311

12,748

10,920

13,304

Weighted-average diluted shares

944,893

935,944

943,185

934,549

Basic earnings per common share

12.45

6.49

26.48

13.02

Diluted earnings per common share

12.30

6.40

26.17

12.83

The number of potentially dilutive securities excluded from the computation of diluted earnings per

common share because their effect would have been antidilutive was not significant for the three- and six-month periods ended March 31, 2012 and March 26, 2011.

Fair Value Measurements

Fair value is the price that would be received

from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value

into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

Level 1 Quoted prices in active markets for identical assets or liabilities.

Level 2 Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets,

or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3 Inputs that are generally unobservable and typically reflect management s estimate of assumptions that market participants would use in pricing the asset or liability.

Note 2 Financial Instruments

Cash, Cash Equivalents and Marketable Securities

The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category

recorded as cash and cash equivalents or short-term or long-term marketable securities as of March 31, 2012 and September 24, 2011 (in millions):

September 30,

September 30,

September 30,

September 30,

September 30,

September 30,

September 30,

March 31, 2012

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

2,911

2,911

2,911

Level 1:

Money market funds

1,513

1,513

1,513

Mutual funds

1,255

(5

1,258

1,258

Subtotal

2,768

(5

2,771

1,513

1,258

Level 2:

U.S. Treasury securities

18,469

10

(17

18,462

1,278

3,831

13,353

U.S. agency securities

21,130

35

(8

21,157

1,827

2,781

16,549

Non-U.S. government securities

5,326

78

(4

5,400

1,661

3,739

Certificates of deposit and time deposits

2,885

2,887

986

339

1,562

Commercial paper

2,545

2,545

1,497

1,048

Corporate securities

43,391

307

(32

43,666

85

6,856

36,725

Municipal securities

4,792

53

(5

4,840

24

640

4,176

Mortgage and asset-backed securities

5,535

(5

5,537

5,534

Subtotal

104,073

492

(71

104,494

5,697

17,159

81,638

Total

109,752

500

(76

110,176

10,121

18,417

81,638

September 30,

September 30,

September 30,

September 30,

September 30,

September 30,

September 30,

September 24, 2011

Adjusted

Cost

Unrealized

Gains

Unrealized

Losses

Fair

Value

Cash and

Cash

Equivalents

Short-Term

Marketable

Securities

Long-Term

Marketable

Securities

Cash

2,903

2,903

2,903

Level 1:

Money market funds

1,911

1,911

1,911

Mutual funds

1,227

(34

1,193

1,193

Subtotal

3,138

(34

3,104

1,911

1,193

Level 2:

U.S. Treasury securities

10,717

39

(3

10,753

1,250

2,149

7,354

U.S. agency securities

13,467

24

(3

13,488

225

1,818

11,445

Non-U.S. government securities

5,559

11

(2

5,568

551

1,548

3,469

Certificates of deposit and time deposits

4,175

(2

4,175

728

977

2,470

Commercial paper

2,853

2,853

2,237

616

Corporate securities

35,241

132

(114

35,259

10

7,241

28,008

Municipal securities

3,411

56

3,467

595

2,872

Subtotal

75,423

264

(124

75,563

5,001

14,944

55,618

Total

81,464

264

(158

81,570

9,815

16,137

55,618

The net unrealized gains as of March 31, 2012 and September 24, 2011 are related primarily to

long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The

Company recognized no significant net realized gains or losses during the three- and six-month periods ended March 31, 2012 and March 26, 2011 related to such sales. The maturities of the Company s long-term marketable securities

generally range from one to five years.

As of March 31, 2012 and September 24, 2011, gross unrealized losses

related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.

The Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature. The

Company typically invests in highly-rated securities, and its policy generally limits the amount of credit exposure to any one issuer. The Company s investment policy requires investments to generally be investment grade, with the primary

objective of minimizing the potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company reviews factors such

as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, and the Company s intent to sell, or whether it is more likely than not it will be required to

sell the investment before recovery of the investment s cost basis. During the three- and six-month periods ended March 31, 2012 and March 26, 2011, the Company did not recognize any significant impairment charges. As of

March 31, 2012, the Company does not consider any of its investments to be other-than-temporarily impaired.

Derivative Financial

Instruments

The Company uses derivatives to partially offset its business exposure to foreign currency exchange risk. The

Company may enter into foreign currency forward and option contracts to offset some of the foreign exchange risk on expected future cash flows on certain forecasted revenue and cost of sales, on net investments in certain foreign subsidiaries, and

on certain existing assets and liabilities.

To help protect gross margins from fluctuations in foreign currency exchange rates, certain

of the Company s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies

may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases

generally up to six months.

To help protect the net investment in a foreign operation from adverse changes in foreign

currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.

The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and

losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not

limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency

exchange rates.

The Company records all derivatives on the Condensed Consolidated Balance Sheets at fair value. The

Company s accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in accumulated other comprehensive income

( AOCI ) until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. The ineffective portions of cash flow

hedges and net investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item the derivative relates to.

The Company had a net deferred gain associated with cash flow hedges of approximately $105 million and $290 million, net of

taxes, recorded in AOCI as of March 31, 2012 and September 24, 2011, respectively. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the

related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Substantially all of the

Company s hedged transactions as of March 31, 2012 are expected to occur within six months.

Derivative instruments

designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in

AOCI associated with such derivative instruments are reclassified immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are reflected in other income and expense unless they are re-designated

as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during the three- and six-month periods ended March 31, 2012 and

March 26, 2011.

The Company s unrealized net gains and losses on net investment hedges, included in the cumulative

translation adjustment account of AOCI, were not significant as of March 31, 2012 and September 24, 2011, respectively. The ineffective portions and amounts excluded from the effectiveness test of net investment hedges are recorded in

other income and expense.

During the three and six months ended March 31, 2012 and March 26, 2011, the gain/loss

recognized in other income and expense for foreign currency forward and option contracts not designated as hedging instruments was not significant. These amounts represent the net gain or loss on the derivative contracts and do not include changes

in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts.

The following table shows the notional principal amounts of the Company s outstanding

derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of March 31, 2012 and September 24, 2011 (in millions):

September 30,

September 30,

September 30,

September 30,

March 31, 2012

September 24, 2011

Notional

Principal

Credit Risk

Amounts

Notional

Principal

Credit Risk

Amounts

Instruments qualifying as accounting hedges:

Foreign exchange contracts

20,505

336

13,705

537

Instruments other than accounting hedges:

Foreign exchange contracts

13,585

43

9,891

56

The notional principal amounts for outstanding derivative instruments provide one measure of the

transaction volume outstanding and does not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that

are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates at each respective date. The Company s gross exposure on these transactions may be

further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function of currency exchange rates. Although the table above reflects the notional principal

and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions that the foreign exchange instruments are intended to hedge. The amounts ultimately

realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.

The Company generally enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with

the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from

contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. The Company received cash collateral related to the derivative instruments under its collateral security

arrangements of $217 million and $288 million as of March 31, 2012 and September 24, 2011, respectively. These amounts are classified as accrued expenses in the Condensed Consolidated Balance Sheets. The Company did not have any derivative

instruments with credit risk-related contingent features that would require it to post additional collateral as of March 31, 2012 or September 24, 2011.

The following tables show the Company s derivative instruments measured at gross fair value as reflected in the Condensed Consolidated Balance Sheets as of March 31, 2012 and September 24,

2011 (in millions):

September 30,

September 30,

September 30,

March 31, 2012

Fair Value of

Derivatives

Designated

as Hedge

Instruments

Fair Value of

Derivatives

Not Designated

as Hedge

Instruments

Total

Fair

Value

Derivative assets (a):

Foreign exchange contracts

308

43

351

Derivative liabilities (b):

Foreign exchange contracts

129

27

156

10

September 30,

September 30,

September 30,

September 24, 2011

Fair Value of

Derivatives

Designated

as Hedge

Instruments

Fair Value of

Derivatives

Not Designated

as

Hedge

Instruments

Total

Fair

Value

Derivative assets (a):

Foreign exchange contracts

460

56

516

Derivative liabilities (b):

Foreign exchange contracts

72

37

109

(a)

The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed

Consolidated Balance Sheets.

(b)

The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed

Consolidated Balance Sheets.

The following table shows the pre-tax effect of the Company s derivative